Kim J - Search Results

1

Novel N-hydroxybenzamides incorporating 2-oxoindoline with unexpected potent histone deacetylase inhibitory effects and antitumor cytotoxicity.

Huong TT, Dung DT, Huan NV, Cuong LV, Hai PT, Huong LT, Kim J, Kim YG, Han SB, Nam NH. Huong TT, et al. Among authors: kim j, kim yg. Bioorg Chem. 2017 Apr;71:160-169. doi: 10.1016/j.bioorg.2017.02.002. Epub 2017 Feb 8. Bioorg Chem. 2017. PMID: 28196602

2

Novel 3-substituted-2-oxoindoline-based N-hydroxypropenamides as histone deacetylase inhibitors and antitumor agents.

Dung do TM, Dung PT, Oanh DT, Hai PT, Huong le TT, Loi VD, Hahn H, Han BW, Kim J, Han SB, Nam NH. Dung do TM, et al. Among authors: kim j. Med Chem. 2015;11(8):725-35. doi: 10.2174/1573406411666150702130633. Med Chem. 2015. PMID: 26133355

3

Design, synthesis and evaluation of novel N-hydroxybenzamides/N-hydroxypropenamides incorporating quinazolin-4(3H)-ones as histone deacetylase inhibitors and antitumor agents.

Hieu DT, Anh DT, Tuan NM, Hai PT, Huong LT, Kim J, Kang JS, Vu TK, Dung PTP, Han SB, Nam NH, Hoa ND. Hieu DT, et al. Among authors: kim j. Bioorg Chem. 2018 Feb;76:258-267. doi: 10.1016/j.bioorg.2017.12.007. Epub 2017 Dec 5. Bioorg Chem. 2018. PMID: 29223029

4

Novel Hydroxamic Acids Incorporating 1-((1H-1,2,3-Triazol-4-yl)methyl)- 3-substituted-2-oxoindolines: Synthesis, Biological Evaluation and SAR Analysis.

Dung DTM, Huan NV, Cam DM, Hieu DC, Hai PT, Huong LT, Kim J, Choi JE, Kang JS, Han SB, Nam NH. Dung DTM, et al. Among authors: kim j. Med Chem. 2018;14(8):831-850. doi: 10.2174/1573406414666180528111749. Med Chem. 2018. PMID: 29807520

5

Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells.

Kim JS, Kim YG, Pyo M, Lee HK, Hong JT, Kim Y, Han SB. Kim JS, et al. Immune Netw. 2015 Apr;15(2):58-65. doi: 10.4110/in.2015.15.2.58. Epub 2015 Apr 23. Immune Netw. 2015. PMID: 25922594 Free PMC article. Review.

6

Cd226^-/- natural killer cells fail to establish stable contacts with cancer cells and show impaired control of tumor metastasis in vivo.

Kim JS, Shin BR, Lee HK, Lee JH, Kim KH, Choi JE, Ji AY, Hong JT, Kim Y, Han SB. Kim JS, et al. Oncoimmunology. 2017 Jul 5;6(8):e1338994. doi: 10.1080/2162402X.2017.1338994. eCollection 2017. Oncoimmunology. 2017. PMID: 28920003 Free PMC article.

7

Characterization of morphological changes of B16 melanoma cells under natural killer cell attack.

Kim JS, Kim B, Lee HK, Kim HS, Park EJ, Choi YJ, Ahn GB, Yun J, Hong JT, Kim Y, Han SB. Kim JS, et al. Among authors: kim b, kim hs, kim y. Int Immunopharmacol. 2019 Feb;67:366-371. doi: 10.1016/j.intimp.2018.12.037. Epub 2018 Dec 21. Int Immunopharmacol. 2019. PMID: 30583235

8

Bisabolangelone inhibits dendritic cell functions by blocking MAPK and NF-κB signaling.

Kim HS, Lee YJ, Lee HK, Kim JS, Park Y, Kang JS, Hwang BY, Hong JT, Kim Y, Han SB. Kim HS, et al. Food Chem Toxicol. 2013 Sep;59:26-33. doi: 10.1016/j.fct.2013.05.013. Epub 2013 May 28. Food Chem Toxicol. 2013. PMID: 23727177

9

Preclinical and clinical studies on cytokine-induced killer cells for the treatment of renal cell carcinoma.

Kim JS, Chung IS, Lim SH, Park Y, Park MJ, Kim JY, Kim YG, Hong JT, Kim Y, Han SB. Kim JS, et al. Arch Pharm Res. 2014 May;37(5):559-66. doi: 10.1007/s12272-014-0381-x. Epub 2014 Apr 2. Arch Pharm Res. 2014. PMID: 24691830 Review.

10

Cell-based Immunotherapy for Colorectal Cancer with Cytokine-induced Killer Cells.

Kim JS, Kim YG, Park EJ, Kim B, Lee HK, Hong JT, Kim Y, Han SB. Kim JS, et al. Immune Netw. 2016 Apr;16(2):99-108. doi: 10.4110/in.2016.16.2.99. Epub 2016 Apr 28. Immune Netw. 2016. PMID: 27162526 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135,315 results

Search Page

Filters